Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 0R9T.L
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio 0.00 1.22 1.22
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -42.88 1.45 2.54
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 1.07 14.59 14.43
Cash 1.07 3.64 3.60
Capex 15.04 -0.34 -0.40
Free Cash Flow -46.86 0.12 -0.24
Revenue 102.14 7.13 3.53
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin -19.75 0.26 0.33
Operating Margin 1.36 0.26 0.26
ROA 100.00 0.06 0.03
ROE 100.00 0.11 0.06
ROIC 107.02 0.09 0.04
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 0R9T.L is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 0R9T.L is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 0R9T.L is permitted for members.